TY  - SOUND
AU  - Holgate,S.T.
TI  - Update on the SNG001 drug, an INFbeta therapy for COVID-19
T2  - Interviews on Covid-19,
PY  - 2020///
CY  - London
PB  - Henry Stewart Talks
KW  - Antiviral agents
KW  - Development
KW  - Clinical trials
KW  - Coronavirus infections
KW  - Chemotherapy
KW  - COVID-19 (Disease)
KW  - Prevention
KW  - Treatment
KW  - Interferon
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Clinical Trials, Phase II as Topic
KW  - drug therapy
KW  - prevention & control
KW  - COVID-19
KW  - Interferon-beta
KW  - therapeutic use
KW  - Nebulizers and Vaporizers
KW  - Pneumonia, Viral
KW  - Precision Medicine
KW  - SARS-CoV-2
KW  - Treatment Outcome
N1  - Audio interview; Title from title frames; Contents: An overview of SNG001 therapy -- Findings of the phase 2 clinical trial -- Treatment potential at different stages of the disease -- Advantages of the treatment delivery mode and accessibility -- Potential use as a prophylaxis treatment -- Follow up clinical trials to be undertaken -- Other treatment settings for INFβ; Access restricted to subscribers
UR  - https://hstalks.com/bs/4467/
UR  - https://hstalks.com/bs/p/1060/
ER  -